Loading company…
Yuce Bio is a Shenzhen-based tumor immune diagnosis company that develops neoantigen detection tests and companion diagnostics.
Based in Shenzhen, China and established in 2015, Yuce Bio operates a tumor immune diagnosis and treatment platform built around tumor neoantigen detection. It provides clinical medication guidance, dynamic monitoring and testing products for tumor patients, along with companion diagnosis and target development services for pharmaceutical companies. Its business covers more than 40 cities and 200 hospitals. The company is listed at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in